Clinical Trials Directory

Trials / Conditions / Dementia With Lewy Bodies (DLB)

Dementia With Lewy Bodies (DLB)

14 registered clinical trials studyying Dementia With Lewy Bodies (DLB) — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDigital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
NCT07240805
BioSensics—
Enrolling By InvitationRetrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a
NCT07314190
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau—
RecruitingUltra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NCT07509125
Universitaire Ziekenhuizen KU LeuvenN/A
Enrolling By InvitationProspective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers a
NCT07239843
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau—
Not Yet RecruitingContribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies
NCT07166744
University Hospital, Strasbourg, FranceN/A
Recruiting[18F]ACI-15916 PET in α-synucleinopathies
NCT06891703
AC Immune SAEARLY_Phase 1
CompletedA Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
NCT06815965
EIP Pharma IncPhase 2
WithdrawnBiomarkers in Neurodegenerative Diseases
NCT04055532
University of Minnesota—
CompletedCognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies
NCT04001517
EIP Pharma IncPhase 2
CompletedADDIA Proof-of-Performance Clinical Study
NCT03030586
Amoneta Diagnostics SAS—
CompletedA Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
NCT01278407
Eisai Co., Ltd.Phase 3
CompletedDonepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (D
NCT00776347
Osaka UniversityN/A
CompletedA Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
NCT00598650
Eisai Co., Ltd.Phase 2
CompletedA Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Stud
NCT00543855
Eisai Co., Ltd.Phase 2